Understanding the unique challenges in testing bioequivalence for combination products like fixed-dose combos and drug-device systems. Learn why generic versions take longer to approve and the latest regulatory solutions.
Bioequivalence testing ensures generic drugs perform the same as brand-name versions. Learn how this science protects patient safety, saves billions, and keeps millions of people on affordable, effective medication.
Generic drugs save up to 85% on prescription costs and are just as safe and effective as brand-name versions. Learn how the FDA ensures they work the same, when to stick with brand-name, and why 90% of prescriptions are now generic.